XML 65 R44.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Employee Benefit Plans and Similar Obligations | 12 Months Ended
--- | ---
Dec. 31, 2023
Text block [abstract] |
Employee Benefit Plans and Similar Obligations | 37. EMPLOYEE BENEFIT PLANS AND SIMILAR OBLIGATIONS Retirement plan Effective March 1, 1995, the Group has established a retirement plan, through which it makes contributions to a mutual fund for an amount equivalent to the amount contributed by each adhering member, between 3% and 10% of their monthly compensation, and has no legal or constructive obligation to make additional contributions in the event that the mutual fund does not have sufficient assets to meet the benefits. The plan members will receive from the Group the contributed funds before retirement only in the case of voluntary termination under certain circumstances, dismissal without cause or in case of death or incapacity. The Group has the right to discontinue this plan at any time, without incurring termination costs. The amount charged to expense related to the retirement plan was 3, 4 and 3 for the years ended December 31, 2023, 2022 and 2021, respectively. Objective performance bonus programs and performance evaluation programs These programs cover certain of the Group’s personnel and are paid in cash. These bonuses are based on compliance with corporate objectives, business unit objectives and individual performance. They are calculated considering the annual compensation of each employee, certain key factors related to the fulfillment of these objectives and the performance evaluation of each employee. The amount charged to expense related to the objective performance bonus programs and performance evaluation programs was 111, 122 and 73 for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based benefit plans From the fiscal year 2013 the Company has decided to implement a share-based benefit plan aimed at aligning the performance of certain executive-level employees, managers and key or critical technical knowledgeable personnel, with the objectives of the strategic plan of the Company. This plan, organized in annual programs, consists in giving participation, through shares of the Company, to each selected employee with the condition of remaining in it for the period defined in the plan (period of up to 3 years from the grant date, hereinafter “service period”), being this the only necessary condition to access the agreed final retribution. Consistent with and with similar characteristics to share-based benefit plans approved in previous years, the Company’s Board of Directors:
| - | at its meeting held on May 8, 2018, approved the creation of a new shared-based benefit plan for 2018-2021 effective for 3 years from July 1, 2018.
| - | at its meeting held on May 9, 2019, approved the creation of a new shared-based benefit plan for 2019-2022 effective for 3 years from July 1, 2019.
| - | at its meeting held on November 10, 2020, approved the creation of a new shared-based benefit plan for 2020-2023 effective for 3 years from July 1, 2020.
| - | at its meeting held on September 23, 2021, approved the creation of a new shared-based benefit plan for 2021-2024 effective for 3 years from July 1, 2021.
| - | at its meeting held on September 15, 2022, approved the creation of a new shared-based benefit plan for 2022-2025 effective for 3 years from August 1, 2022.
| - | at its meeting held on August 16, 2023, approved the creation of a new shared-based benefit plan for 2023-2026 effective for 3 years from August 1, 2023.
Moreover, the 2019 - 2022 Plan was supplemented with an additional U.S. dollar amount, with the same vesting as the share-based benefit plan, to be paid in pesos at the exchange rate in force on the date of such vesting. This supplement has no significant effects. Besides, it was defined that the 2021 - 2024 Plan would be paid in cash. Such change in the conditions of the Plan does not have any significant effects. Note 2.b.11) describes the accounting policies for share-based benefit plans. Repurchases of treasury shares are disclosed in Note 30. Information related to the evolution of the quantity of shares, of the share-based benefit plans at the end of the years ended December 31, 2023, 2022 and 2021, is as follows: Plan 2018 - 2021
|  | 2023 |  |  | 2022 |  |  | 2021 |  |  |  |  |  |
Amount at the beginning of the fiscal year |  |  | - |  |  |  | - |  |  |  | 237,082 |  |  |  |  |
- Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
- Settled |  |  | - |  |  |  | - |  |  |  | (230,254) |  |  |  |  |
- Expired |  |  | - |  |  |  | - |  |  |  | (6,828) |  |  |  |  |
Amount at the end of the fiscal year (1) |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Expense recognized during the fiscal year |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (2) |
Fair value of shares on grant date (in U.S. dollars) |  |  | - |  |  |  | - |  |  |  | 13.60 |  |  |  |  |
(1) | The life of the plan in 2021 was 7 months.
(2) | Registered value less than 1.
Plan 2019 - 2022
|  | 2023 |  |  | 2022 |  |  |  |  | 2021 |
Amount at the beginning of the fiscal year |  |  | - |  |  |  | 258,904 |  |  |  |  |  | 467,368 |
- Granted |  |  | - |  |  |  | - |  |  |  |  |  | - |
- Settled |  |  | - |  |  |  | (192,225) |  |  |  |  |  | (182,510) |
- Expired |  |  | - |  |  |  | (66,679) |  |  |  |  |  | (25,954) |
Amount at the end of the fiscal year (1) |  |  | - |  |  |  | - |  |  |  |  |  | 258,904 |
Expense recognized during the fiscal year |  |  | - |  |  |  | - |  |  | (2) |  |  | 2 |
Fair value of shares on grant date (in U.S. dollars) |  |  | - |  |  |  | 9.97 |  |  |  |  |  | 9.97 |
(1) | The life of the plan in 2022 was 7 months, whereas the remaining life of the plan was 7 months as of December 31, 2021.
(2) | Registered value less than 1.
Plan 2020 - 2023
|  | 2023 |  |  |  |  | 2022 |  |  | 2021 |
Amount at the beginning of the fiscal year |  |  | 350,796 |  |  |  |  |  | 681,529 |  |  |  | 985,900 |
- Granted |  |  | - |  |  |  |  |  | - |  |  |  | - |
- Settled |  |  | (271,817) |  |  |  |  |  | (308,298) |  |  |  | (263,914) |
- Expired |  |  | (78,979) |  |  |  |  |  | (22,435) |  |  |  | (40,457) |
Amount at the end of the fiscal year (1) |  |  | - |  |  |  |  |  | 350,796 |  |  |  | 681,529 |
Expense recognized during the fiscal year |  |  | - |  |  | (2) |  |  | 1 |  |  |  | 2 |
Fair value of shares on grant date (in U.S. dollars) |  |  | 4.75 |  |  |  |  |  | 4.75 |  |  |  | 4.75 |
(1) | The life of the plan in 2023 was 7 months, whereas the average remaining life of the plan was 7 months as of December 31, 2022, and between 7 and 19 months as of December 31, 2021.
(2) | Registered value less than 1.
Plan 2021 - 2024
|  | 2023 |  |  | 2022 |  |  | 2021 |
Amount at the beginning of the fiscal year |  |  | 818,823 |  |  |  | 1,252,400 |  |  |  | - |
- Granted |  |  | 50,037 |  |  |  | - |  |  |  | 1,252,400 |
- Settled |  |  | (367,371) |  |  |  | (418,598) |  |  |  | - |
- Expired |  |  | (23,392) |  |  |  | (14,979) |  |  |  | - |
Amount at the end of the fiscal year (1) |  |  | 478,097 |  |  |  | 818,823 |  |  |  | 1,252,400 |
Expense recognized during the fiscal year |  |  | 17 |  |  |  | 6 |  |  |  | 2 |
Fair value of shares on grant date (in U.S. dollars) |  |  | 36.43 |  |  |  | 8.00 |  |  |  | 8.00 |
(1) | The average remaining life of the plan is 7 months as of December 31, 2023, whereas the remaining life of the plan was between 7 and 19 months as of December 31, 2022, and between 7 and 31 months as of December 31, 2021.
Plan 2022 - 2025
|  | 2023 |  |  | 2022 |  |  | 2021 |
Amount at the beginning of the fiscal year |  |  | 962,150 |  |  |  | - |  |  |  | - |
- Granted |  |  | 69,176 |  |  |  | 962,150 |  |  |  | - |
- Settled |  |  | (320,649) |  |  |  | - |  |  |  | - |
- Expired |  |  | (69,516) |  |  |  | - |  |  |  | - |
Amount at the end of the fiscal year (1) |  |  | 641,161 |  |  |  | 962,150 |  |  |  | - |
Expense recognized during the fiscal year |  |  | 2 |  |  |  | 1 |  |  |  | - |
Fair value of shares on grant date (in U.S. dollars) |  |  | 6.67 |  |  |  | 6.67 |  |  |  | - |
(1) | The average remaining life of the plan is between 8 and 20 months as of December 21, 2023, whereas the average remaining life of the plan was between 8 and 32 months as of December 31, 2022.
Plan 2023 - 2026
|  | 2023 |  |  |  |  | 2022 |  |  | 2021 |
Amount at the beginning of the fiscal year |  |  | - |  |  |  |  |  | - |  |  |  | - |
- Granted |  |  | 778,756 |  |  | (2) |  |  | - |  |  |  | - |
- Settled |  |  | (7,473) |  |  |  |  |  | - |  |  |  | - |
- Expired |  |  | (50,915) |  |  |  |  |  | - |  |  |  | - |
Amount at the end of the fiscal year (1) |  |  | 720,368 |  |  |  |  |  | - |  |  |  | - |
Expense recognized during the fiscal year |  |  | 1 |  |  |  |  |  | - |  |  |  | - |
Fair value of shares on grant date (in U.S. dollars) |  |  | 14.63 |  |  |  |  |  | - |  |  |  | - |
(1) | The average remaining life of the plan is between 8 and 32 months as of December 31, 2023.
(2) | Includes an allocation of 47,650 shares with settlement upon plan expiration.

X
- Definition Tabular disclosure of employee benefit plans and share based payments + References No definition available. + Details
Name: | ypf_DisclosureOfEmployeeBenefitPlansAndShareBasedPaymentsExplanatory
Namespace Prefix: | ypf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Text block [abstract] + References No definition available. + Details
Name: | ypf_TextBlockAbstract
Namespace Prefix: | ypf_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration